MCL coexpression mm9:1285
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr11:33947115..33947242,+ | p1@Lcp2 |
Mm9::chr1:140071815..140071831,- | p2@Ptprc |
Mm9::chr6:129187043..129187060,- | p@chr6:129187043..129187060 - |
Mm9::chr6:129187190..129187197,- | p@chr6:129187190..129187197 - |
Mm9::chrX:98463521..98463548,- | p1@Il2rg |
Mm9::chrX:98463557..98463568,- | p2@Il2rg |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0045321 | leukocyte activation | 0.000201384263337577 |
GO:0001775 | cell activation | 0.000201384263337577 |
GO:0050870 | positive regulation of T cell activation | 0.00124494442873144 |
GO:0051251 | positive regulation of lymphocyte activation | 0.00134529211205477 |
GO:0030217 | T cell differentiation | 0.00134529211205477 |
GO:0050863 | regulation of T cell activation | 0.00134529211205477 |
GO:0002376 | immune system process | 0.00167704470278518 |
GO:0051249 | regulation of lymphocyte activation | 0.00167704470278518 |
GO:0050865 | regulation of cell activation | 0.00167704470278518 |
GO:0030098 | lymphocyte differentiation | 0.00172823782179823 |
GO:0042110 | T cell activation | 0.0025884242134679 |
GO:0002521 | leukocyte differentiation | 0.00270282578494193 |
GO:0001915 | negative regulation of T cell mediated cytotoxicity | 0.00270282578494193 |
GO:0009897 | external side of plasma membrane | 0.00270282578494193 |
GO:0009986 | cell surface | 0.00323981682805191 |
GO:0046649 | lymphocyte activation | 0.00323981682805191 |
GO:0001960 | negative regulation of cytokine and chemokine mediated signaling pathway | 0.00323981682805191 |
GO:0045591 | positive regulation of regulatory T cell differentiation | 0.00323981682805191 |
GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 0.00323981682805191 |
GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 0.00323981682805191 |
GO:0045589 | regulation of regulatory T cell differentiation | 0.00323981682805191 |
GO:0030097 | hemopoiesis | 0.00323981682805191 |
GO:0048534 | hemopoietic or lymphoid organ development | 0.00323981682805191 |
GO:0019976 | interleukin-2 binding | 0.00323981682805191 |
GO:0001916 | positive regulation of T cell mediated cytotoxicity | 0.00323981682805191 |
GO:0051283 | negative regulation of sequestering of calcium ion | 0.00323981682805191 |
GO:0045066 | regulatory T cell differentiation | 0.00323981682805191 |
GO:0001959 | regulation of cytokine and chemokine mediated signaling pathway | 0.00323981682805191 |
GO:0001914 | regulation of T cell mediated cytotoxicity | 0.00323981682805191 |
GO:0051208 | sequestering of calcium ion | 0.00323981682805191 |
GO:0051238 | sequestering of metal ion | 0.00323981682805191 |
GO:0002711 | positive regulation of T cell mediated immunity | 0.00323981682805191 |
GO:0051282 | regulation of sequestering of calcium ion | 0.00323981682805191 |
GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 0.00323981682805191 |
GO:0051209 | release of sequestered calcium ion into cytosol | 0.00323981682805191 |
GO:0002520 | immune system development | 0.00352060068852258 |
GO:0002709 | regulation of T cell mediated immunity | 0.00387649149020192 |
GO:0001911 | negative regulation of leukocyte mediated cytotoxicity | 0.00387649149020192 |
GO:0001913 | T cell mediated cytotoxicity | 0.00387649149020192 |
GO:0051239 | regulation of multicellular organismal process | 0.00394701093829918 |
GO:0050663 | cytokine secretion | 0.00553048541377863 |
GO:0050853 | B cell receptor signaling pathway | 0.00629826326499603 |
GO:0002456 | T cell mediated immunity | 0.00703023421918479 |
GO:0051607 | defense response to virus | 0.00772883966084589 |
GO:0043367 | CD4-positive, alpha beta T cell differentiation | 0.00903465807306708 |
GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 0.00903465807306708 |
GO:0045576 | mast cell activation | 0.00925205560095098 |
GO:0045582 | positive regulation of T cell differentiation | 0.00925205560095098 |
GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 0.00925205560095098 |
GO:0045621 | positive regulation of lymphocyte differentiation | 0.0103017317491084 |
GO:0002705 | positive regulation of leukocyte mediated immunity | 0.0103017317491084 |
GO:0051235 | maintenance of localization | 0.0103017317491084 |
GO:0001910 | regulation of leukocyte mediated cytotoxicity | 0.0103017317491084 |
GO:0031341 | regulation of cell killing | 0.0103017317491084 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 0.0103017317491084 |
GO:0002699 | positive regulation of immune effector process | 0.0107011816398053 |
GO:0045580 | regulation of T cell differentiation | 0.0107011816398053 |
GO:0002703 | regulation of leukocyte mediated immunity | 0.0107011816398053 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 0.0107011816398053 |
GO:0002706 | regulation of lymphocyte mediated immunity | 0.0107011816398053 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.0109645567172291 |
GO:0002821 | positive regulation of adaptive immune response | 0.0109645567172291 |
GO:0002697 | regulation of immune effector process | 0.0112114061902319 |
GO:0051480 | cytosolic calcium ion homeostasis | 0.0112114061902319 |
GO:0046632 | alpha-beta T cell differentiation | 0.0120389508307953 |
GO:0001906 | cell killing | 0.0120389508307953 |
GO:0002819 | regulation of adaptive immune response | 0.0120389508307953 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. | 0.0120389508307953 |
GO:0001909 | leukocyte mediated cytotoxicity | 0.0120389508307953 |
GO:0045619 | regulation of lymphocyte differentiation | 0.0124056933686874 |
GO:0042102 | positive regulation of T cell proliferation | 0.0135893450616824 |
GO:0002274 | myeloid leukocyte activation | 0.0135893450616824 |
GO:0050851 | antigen receptor-mediated signaling pathway | 0.0135893450616824 |
GO:0042100 | B cell proliferation | 0.0135893450616824 |
GO:0005925 | focal adhesion | 0.0135893450616824 |
GO:0009306 | protein secretion | 0.0148981474371567 |
GO:0005924 | cell-substrate adherens junction | 0.0149991928481333 |
GO:0046631 | alpha-beta T cell activation | 0.0149991928481333 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 0.01528621194509 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 0.0154348204545951 |
GO:0030055 | cell-matrix junction | 0.0154348204545951 |
GO:0030183 | B cell differentiation | 0.0154348204545951 |
GO:0019965 | interleukin binding | 0.0154348204545951 |
GO:0002757 | immune response-activating signal transduction | 0.0154348204545951 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 0.0154348204545951 |
GO:0006469 | negative regulation of protein kinase activity | 0.0154348204545951 |
GO:0033673 | negative regulation of kinase activity | 0.0154348204545951 |
GO:0050671 | positive regulation of lymphocyte proliferation | 0.0154348204545951 |
GO:0051348 | negative regulation of transferase activity | 0.0159285124615529 |
GO:0002764 | immune response-regulating signal transduction | 0.0159285124615529 |
GO:0042129 | regulation of T cell proliferation | 0.0174079160485435 |
GO:0019221 | cytokine and chemokine mediated signaling pathway | 0.0184455722071303 |
GO:0043086 | negative regulation of catalytic activity | 0.0190561308588889 |
GO:0019901 | protein kinase binding | 0.019244074682621 |
GO:0019838 | growth factor binding | 0.019244074682621 |
GO:0009615 | response to virus | 0.019244074682621 |
GO:0019900 | kinase binding | 0.0194333038375189 |
GO:0050670 | regulation of lymphocyte proliferation | 0.0201798342889598 |
GO:0032944 | regulation of mononuclear cell proliferation | 0.0201798342889598 |
GO:0004896 | hematopoietin/interferon-class (D200-domain) cytokine receptor activity | 0.0203538637423428 |
GO:0042098 | T cell proliferation | 0.0205244061748399 |
GO:0006874 | cellular calcium ion homeostasis | 0.0217964541555786 |
GO:0005912 | adherens junction | 0.0220995211409495 |
GO:0055074 | calcium ion homeostasis | 0.0220995211409495 |
GO:0032501 | multicellular organismal process | 0.0222698414508014 |
GO:0006875 | cellular metal ion homeostasis | 0.0234533739515075 |
GO:0019955 | cytokine binding | 0.0235849228369584 |
GO:0055065 | metal ion homeostasis | 0.0237139974166393 |
GO:0016323 | basolateral plasma membrane | 0.0241848559177353 |
GO:0032943 | mononuclear cell proliferation | 0.0251006750095906 |
GO:0046651 | lymphocyte proliferation | 0.0251006750095906 |
GO:0002253 | activation of immune response | 0.0258808109738987 |
GO:0042113 | B cell activation | 0.0283044698039734 |
GO:0004725 | protein tyrosine phosphatase activity | 0.0283847001189565 |
GO:0002250 | adaptive immune response | 0.0288636487410764 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.0288636487410764 |
GO:0009968 | negative regulation of signal transduction | 0.0289369016177656 |
GO:0048513 | organ development | 0.0290796100339192 |
GO:0002449 | lymphocyte mediated immunity | 0.0290796100339192 |
GO:0030005 | cellular di-, tri-valent inorganic cation homeostasis | 0.0297727236658622 |
GO:0050778 | positive regulation of immune response | 0.0297787211431084 |
GO:0055066 | di-, tri-valent inorganic cation homeostasis | 0.0297787211431084 |
GO:0002684 | positive regulation of immune system process | 0.0297787211431084 |
GO:0002443 | leukocyte mediated immunity | 0.0297787211431084 |
GO:0001816 | cytokine production | 0.0297787211431084 |
GO:0030003 | cellular cation homeostasis | 0.0310259053456914 |
GO:0006470 | protein amino acid dephosphorylation | 0.0313701166319096 |
GO:0055080 | cation homeostasis | 0.0314169453428553 |
GO:0050776 | regulation of immune response | 0.0321720903223131 |
GO:0044459 | plasma membrane part | 0.0321720903223131 |
GO:0002682 | regulation of immune system process | 0.0324081502288187 |
GO:0051240 | positive regulation of multicellular organismal process | 0.0332938216522709 |
GO:0016311 | dephosphorylation | 0.0333240854308479 |
GO:0045859 | regulation of protein kinase activity | 0.0355805098648134 |
GO:0006917 | induction of apoptosis | 0.0356054391453159 |
GO:0012502 | induction of programmed cell death | 0.0356054391453159 |
GO:0043549 | regulation of kinase activity | 0.0361615764838792 |
GO:0019899 | enzyme binding | 0.0361695157330812 |
GO:0002252 | immune effector process | 0.0361849658594344 |
GO:0051338 | regulation of transferase activity | 0.0361849658594344 |
GO:0048731 | system development | 0.0368141696897198 |
GO:0004721 | phosphoprotein phosphatase activity | 0.0375024831801309 |
GO:0048869 | cellular developmental process | 0.0375024831801309 |
GO:0030154 | cell differentiation | 0.0375024831801309 |
GO:0055082 | cellular chemical homeostasis | 0.0375024831801309 |
GO:0006873 | cellular ion homeostasis | 0.0375024831801309 |
GO:0043065 | positive regulation of apoptosis | 0.0414571660600049 |
GO:0051707 | response to other organism | 0.0414571660600049 |
GO:0043068 | positive regulation of programmed cell death | 0.0414571660600049 |
GO:0050801 | ion homeostasis | 0.0414571660600049 |
GO:0008284 | positive regulation of cell proliferation | 0.0436395050356169 |
GO:0005886 | plasma membrane | 0.0453843086993348 |
GO:0048856 | anatomical structure development | 0.0456400827179775 |
Relative expression of the co-expression cluster over median <br>Analyst:
"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |